This study is assessing the safety and immunogenicity of ferritin nanoparticles expressing native-like HIV-1 envelope trimers followed by an mRNA boost in adults without HIV between the ages of 18 to 55 . This study is currently enrolling participants.
Center for Virology and Vaccine Research
3 Blackfan Circle
Boston, MA 02115 – USA
CVVR Clinical Trials Unit